First Time Loading...

Fagron NV
XBRU:FAGR

Watchlist Manager
Fagron NV Logo
Fagron NV
XBRU:FAGR
Watchlist
Price: 18.76 EUR -0.64% Market Closed
Updated: May 21, 2024

Intrinsic Value

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. [ Read More ]

The intrinsic value of one FAGR stock under the Base Case scenario is 24.44 EUR. Compared to the current market price of 18.76 EUR, Fagron NV is Undervalued by 23%.

Key Points:
FAGR Intrinsic Value
Base Case
24.44 EUR
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Fagron NV

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling FAGR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Fagron NV

Provide an overview of the primary business activities
of Fagron NV.

What unique competitive advantages
does Fagron NV hold over its rivals?

What risks and challenges
does Fagron NV face in the near future?

Summarize the latest earnings call
of Fagron NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fagron NV.

Provide P/S
for Fagron NV.

Provide P/E
for Fagron NV.

Provide P/OCF
for Fagron NV.

Provide P/FCFE
for Fagron NV.

Provide P/B
for Fagron NV.

Provide EV/S
for Fagron NV.

Provide EV/GP
for Fagron NV.

Provide EV/EBITDA
for Fagron NV.

Provide EV/EBIT
for Fagron NV.

Provide EV/OCF
for Fagron NV.

Provide EV/FCFF
for Fagron NV.

Provide EV/IC
for Fagron NV.

Show me price targets
for Fagron NV made by professional analysts.

What are the Revenue projections
for Fagron NV?

How accurate were the past Revenue estimates
for Fagron NV?

What are the Net Income projections
for Fagron NV?

How accurate were the past Net Income estimates
for Fagron NV?

What are the EPS projections
for Fagron NV?

How accurate were the past EPS estimates
for Fagron NV?

What are the EBIT projections
for Fagron NV?

How accurate were the past EBIT estimates
for Fagron NV?

Compare the revenue forecasts
for Fagron NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fagron NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fagron NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fagron NV compared to its peers.

Compare the P/E ratios
of Fagron NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Fagron NV with its peers.

Analyze the financial leverage
of Fagron NV compared to its main competitors.

Show all profitability ratios
for Fagron NV.

Provide ROE
for Fagron NV.

Provide ROA
for Fagron NV.

Provide ROIC
for Fagron NV.

Provide ROCE
for Fagron NV.

Provide Gross Margin
for Fagron NV.

Provide Operating Margin
for Fagron NV.

Provide Net Margin
for Fagron NV.

Provide FCF Margin
for Fagron NV.

Show all solvency ratios
for Fagron NV.

Provide D/E Ratio
for Fagron NV.

Provide D/A Ratio
for Fagron NV.

Provide Interest Coverage Ratio
for Fagron NV.

Provide Altman Z-Score Ratio
for Fagron NV.

Provide Quick Ratio
for Fagron NV.

Provide Current Ratio
for Fagron NV.

Provide Cash Ratio
for Fagron NV.

What is the historical Revenue growth
over the last 5 years for Fagron NV?

What is the historical Net Income growth
over the last 5 years for Fagron NV?

What is the current Free Cash Flow
of Fagron NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fagron NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fagron NV

Current Assets 335.9m
Cash & Short-Term Investments 137.3m
Receivables 84.7m
Other Current Assets 113.9m
Non-Current Assets 671.1m
Long-Term Investments 6.7m
PP&E 147.9m
Intangibles 482.9m
Other Non-Current Assets 33.5m
Current Liabilities 175.3m
Accounts Payable 104.9m
Accrued Liabilities 33.9m
Other Current Liabilities 36.5m
Non-Current Liabilities 367.9m
Long-Term Debt 357.1m
Other Non-Current Liabilities 10.9m
Efficiency

Earnings Waterfall
Fagron NV

Revenue
763m EUR
Cost of Revenue
-430.4m EUR
Gross Profit
332.6m EUR
Operating Expenses
-221.5m EUR
Operating Income
111.1m EUR
Other Expenses
-40.5m EUR
Net Income
70.5m EUR

Free Cash Flow Analysis
Fagron NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

FAGR Profitability Score
Profitability Due Diligence

Fagron NV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
58/100
Profitability
Score

Fagron NV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

FAGR Solvency Score
Solvency Due Diligence

Fagron NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
47/100
Solvency
Score

Fagron NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FAGR Price Targets Summary
Fagron NV

Wall Street analysts forecast FAGR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FAGR is 21.51 EUR with a low forecast of 18.33 EUR and a high forecast of 25.2 EUR.

Lowest
Price Target
18.33 EUR
2% Downside
Average
Price Target
21.51 EUR
15% Upside
Highest
Price Target
25.2 EUR
34% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Fagron NV

Shareholder Return

FAGR Price
Fagron NV

1M 1M
+5%
6M 6M
+9%
1Y 1Y
+9%
3Y 3Y
+0%
5Y 5Y
+8%
10Y 10Y
-43%
Annual Price Range
18.76
52w Low
14.74
52w High
19
Price Metrics
Average Annual Return -5.24%
Standard Deviation of Annual Returns 13.75%
Max Drawdown -51%
Shares Statistics
Market Capitalization 1.4B EUR
Shares Outstanding 73 125 273
Percentage of Shares Shorted
N/A

FAGR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Fagron NV Logo
Fagron NV

Country

Belgium

Industry

Health Care

Market Cap

1.4B EUR

Dividend Yield

0%

Description

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,061 full-time employees. The company went IPO on 2007-10-05. The company operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

Contact

OOST-VLAANDEREN
Nazareth
Venecoweg 20A
+3280012880.0
https://fagron.com/

IPO

2007-10-05

Employees

3 061

Officers

CEO & Executive Director
Mr. Rafael Padilla
CFO & Executive Director
Ms. Karin de Jong
Chief Operating Officer
Ms. Vera Bakker
Global Investor Relations Manager
Karen Berg
Head of Legal, Mergers & Acquisitions
Mr. Johan Verlinden

See Also

Discover More
What is the Intrinsic Value of one FAGR stock?

The intrinsic value of one FAGR stock under the Base Case scenario is 24.44 EUR.

Is FAGR stock undervalued or overvalued?

Compared to the current market price of 18.76 EUR, Fagron NV is Undervalued by 23%.